L. D. Kramer

2.3k total citations
25 papers, 1.8k citations indexed

About

L. D. Kramer is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, L. D. Kramer has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 13 papers in Pediatrics, Perinatology and Child Health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in L. D. Kramer's work include Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (8 papers). L. D. Kramer is often cited by papers focused on Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (8 papers). L. D. Kramer collaborates with scholars based in United States, Austria and Argentina. L. D. Kramer's co-authors include Rezaul Karim, R. Reife, Gordon Pledger, Edward Faught, Rǎjesh C. Sachdeo, R. Eugene Ramsay, Richard W. Fincham, Michael Privitera, J. K. Penry and Peter Mesenbrink and has published in prestigious journals such as Neurology, Radiology and The Journal of the Acoustical Society of America.

In The Last Decade

L. D. Kramer

25 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. D. Kramer United States 16 1.4k 1.2k 600 187 167 25 1.8k
Chantal Depondt Belgium 22 819 0.6× 602 0.5× 459 0.8× 280 1.5× 30 0.2× 57 1.6k
Elaine Butler United Kingdom 24 758 0.5× 900 0.7× 339 0.6× 309 1.7× 14 0.1× 34 1.4k
Haruo Hattori Japan 22 319 0.2× 573 0.5× 348 0.6× 132 0.7× 30 0.2× 50 1.5k
Ronald C. Reed United States 17 569 0.4× 462 0.4× 190 0.3× 48 0.3× 57 0.3× 42 789
Xuefeng Wang China 15 727 0.5× 566 0.5× 415 0.7× 72 0.4× 19 0.1× 54 1.0k
H. Siemes Germany 17 443 0.3× 398 0.3× 291 0.5× 53 0.3× 50 0.3× 55 1.1k
Armand Löwenthal Belgium 12 387 0.3× 348 0.3× 307 0.5× 86 0.5× 33 0.2× 24 852
Simona Balestrini Italy 19 673 0.5× 327 0.3× 292 0.5× 44 0.2× 26 0.2× 77 1.3k
David Weintraub United States 10 519 0.4× 514 0.4× 142 0.2× 82 0.4× 42 0.3× 13 829
Luigi Francesco Iannone Italy 20 417 0.3× 147 0.1× 134 0.2× 119 0.6× 174 1.0× 73 1.1k

Countries citing papers authored by L. D. Kramer

Since Specialization
Citations

This map shows the geographic impact of L. D. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. D. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. D. Kramer more than expected).

Fields of papers citing papers by L. D. Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. D. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. D. Kramer. The network helps show where L. D. Kramer may publish in the future.

Co-authorship network of co-authors of L. D. Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of L. D. Kramer. A scholar is included among the top collaborators of L. D. Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. D. Kramer. L. D. Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Sarah, Christopher H. van Dyck, Michelle Gee, et al.. (2023). Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 10(4). 771–777. 50 indexed citations
2.
Kramer, L. D.. (2020). An Industry Perspective: Future of Anti-Amyloid Trials. The Journal of Prevention of Alzheimer s Disease. 7(3). 142–143. 1 indexed citations
3.
Aisen, Paul, Jeffrey L. Cummings, Rachelle S. Doody, et al.. (2020). The Future of Anti-Amyloid Trials. The Journal of Prevention of Alzheimer s Disease. 7(3). 146–151. 43 indexed citations
5.
Satlin, Andrew, L. D. Kramer, & Antonio Laurenza. (2013). Development of perampanel in epilepsy. Acta Neurologica Scandinavica. 127(197). 3–8. 23 indexed citations
6.
Kramer, L. D., Emilio Perucca, Elinor Ben‐Menachem, et al.. (2012). Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures: A Dose Response Analysis from Phase III Studies (P06.117). Neurology. 78(Meeting Abstracts 1). P06.117–P06.117. 8 indexed citations
7.
Kramer, L. D., et al.. (2010). A randomized controlled multicenter trial of high dose ursodesoxycholic acid versus placebo in sepsis-assoicated cholestasis. Zeitschrift für Gastroenterologie. 48(5). 1 indexed citations
8.
Beydoun, Ahmad, Rǎjesh C. Sachdeo, William E. Rosenfeld, et al.. (2000). Oxcarbazepine monotherapy for partial-onset seizures. Neurology. 54(12). 2245–2251. 117 indexed citations
9.
Schachter, Steven C., Blanca Vázquez, Robert S. Fisher, et al.. (1999). Oxcarbazepine. Neurology. 52(4). 732–732. 112 indexed citations
10.
Rosenfeld, William E., Shiyong Liao, L. D. Kramer, et al.. (1997). Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant Therapy. Epilepsia. 38(3). 324–333. 91 indexed citations
11.
Mastrobattista, Joan, et al.. (1997). Antepartum Bilateral Ovarian Vein Thrombosis: Magnetic Resonance Imaging Diagnosis. American Journal of Perinatology. 14(10). 597–599. 5 indexed citations
12.
Base, Wolfgang, et al.. (1997). [Intestinal lavage solution for orthograde intestinal irrigation].. PubMed. 109(5). 165–9. 1 indexed citations
13.
Privitera, Michael, Richard W. Fincham, J. K. Penry, et al.. (1996). Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology. 46(6). 1678–1683. 286 indexed citations
14.
Faught, Edward, R. Eugene Ramsay, R. Reife, et al.. (1996). Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology. 46(6). 1684–1690. 244 indexed citations
15.
Sachdeo, Rǎjesh C., et al.. (1996). Steady‐State Pharmacokinetics of Topiramate and Carbamazepine in Patients with Epilepsy During Monotherapy and Concomitant Therapy. Epilepsia. 37(8). 774–780. 121 indexed citations
16.
Devinsky, Orrin, Edward Faught, B. J. Wilder, et al.. (1995). Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Research. 20(3). 241–246. 46 indexed citations
17.
Kramer, L. D.. (1995). Medical Treatment of Cysticercosis--Ineffective. Archives of Neurology. 52(1). 101–102. 59 indexed citations
18.
Kramer, L. D., et al.. (1989). Cerebral cysticercosis: documentation of natural history with CT.. Radiology. 171(2). 459–462. 111 indexed citations
19.
Rush, James A. & L. D. Kramer. (1979). Biopsy-negative cranial arteritis with complete oculomotor nerve palsy.. PubMed. 11(2). 209–13. 12 indexed citations
20.
Johns, Michael E., et al.. (1978). The effects of cholinesterase antagonists on stapedial reflex behavior. The Journal of the Acoustical Society of America. 63(S1). S43–S43. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026